RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
2.450
-0.100 (-3.92%)
At close: Apr 2, 2025, 4:00 PM
2.538
+0.088 (3.58%)
After-hours: Apr 2, 2025, 5:48 PM EDT

RedHill Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2014 - 2018
Period Ending
Apr '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2014 - 2018
Market Capitalization
32913135302214
Upgrade
Market Cap Growth
150.17%124.48%-90.53%-55.27%41.19%35.98%
Upgrade
Enterprise Value
-424118188353192
Upgrade
Last Close Price
2.4536.50140.302580.008080.006070.00
Upgrade
PE Ratio
-1.20----
Upgrade
PS Ratio
0.524.400.211.584.7034.03
Upgrade
PB Ratio
47.2413.88-0.2615.2321.803.57
Upgrade
P/TBV Ratio
-----4.97
Upgrade
EV/Sales Ratio
2.003.681.922.195.4930.58
Upgrade
Debt / Equity Ratio
9.150.57-2.539.896.270.06
Upgrade
Asset Turnover
0.130.070.360.480.510.09
Upgrade
Inventory Turnover
0.560.452.584.638.781.70
Upgrade
Quick Ratio
0.390.460.280.870.814.66
Upgrade
Current Ratio
0.740.840.441.090.965.01
Upgrade
Return on Equity (ROE)
-1708.61%---859.70%-206.25%-76.09%
Upgrade
Return on Assets (ROA)
-44.88%-15.71%-15.75%-28.06%-31.30%-39.56%
Upgrade
Return on Capital (ROIC)
-401.79%-36.87%-31.32%-51.36%-48.37%-46.96%
Upgrade
Earnings Yield
-961.78%83.26%-560.09%-72.30%-25.20%-19.76%
Upgrade
FCF Yield
-772.47%-124.74%-229.63%-48.20%-16.21%-19.11%
Upgrade
Buyback Yield / Dilution
-697.64%-320.45%-32.46%-27.72%-22.69%-28.43%
Upgrade
Updated Aug 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q